Trial Profile
Clinical Trials Insight: 700049187
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Sep 2009
Price :
$35
*
At a glance
- Drugs Rabeximod (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors OxyPharma
- 25 Sep 2009 New trial record.